Back to Search
Start Over
Alumis opens at $13.50, IPO priced at $16
- Source :
- The Fly. June 28, 2024
- Publication Year :
- 2024
-
Abstract
- Alumis, a clinical-stage biopharmaceutical company developing oral therapies for immune-mediated diseases, priced its initial public offering of 13.125M shares of common stock at an initial public offering price of $16.00 [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.799327645